SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TIENS BIOTECH GR USA (AMEX:TBV)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: VALUESPEC5/24/2005 6:29:58 PM
   of 7
 
Some companies grow revenues by acquisitions. This company is growing organically which makes the growth more impressive. Chinese herbs and other nutritional items are very popular in America and worldwide, including China.

TBV sells not only to China but to 90 other countries as well. International sales started in the last couple years and sales continue to explode. In China distributorships are used and in other countries, where permitted, multilevel marketing is used.

I am familiar with MTEX and USNA which use multilevel marketing to sell nutritional products. These have done very well in the last couple of years especially.

It is my opinion that TBV has a competitive advantage since they have manufacturing and access to true Chinese nutritional ideas and products.

Also, the workforce in china works for relatively low wages and they produce excellent products and put a lot of energy into their work.

These are just some of my thoughts. Previously, my research was not being shared.

TBV: $5.58

Valuespec
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News